Month: May 2021

RT @MDPIpharma: #MDPIPharmaceutics Suprachoroidal targeting of chorioretina in …

RT @MDPIpharma: #MDPIPharmaceutics šŸ“— Suprachoroidal targeting of chorioretina in 4 trials: CLS-AX – AMD, RGXā€314 – AMD/DR & AUā€011 – choroiā€¦ Source by Thomas Ciulla, MD, MBA Return to main website.

RT @RetinalPhys: The Latest on Drug Delivery in the Suprachoroidal Space: Maximi…

RT @RetinalPhys: The Latest on Drug Delivery in the Suprachoroidal Space: Maximize treatment effect and minimize exposure to other ocular tā€¦ Source by Thomas Ciulla, MD, MBA Return to main website.

Congrats to our colleagues & team, who had numerous presentations at this year’s…


Congrats to our colleagues & team, who had numerous presentations at this year’s ARVO on suprachoroidal space delivery platform, gene therapy, CLS-TA, & treatment burden and unmet needs with current anti-VEGF-A therapies…


Source by Thomas Ciulla, MD, MBA

Return to main website.

Retinal OCT for Clinicians via @YouTube…

Retinal OCT for Clinicians https://t.co/rwa3BS3Lew via @YouTube Source by Thomas Ciulla, MD, MBA Return to main website.

RT @RetinalPhys: Our most read article from the April issue is “Retinal OCT Biom…

RT @RetinalPhys: Our most read article from the April issue is “Retinal OCT Biomarkers for Clinicians and Clinical Researchers.” @ThomasCiuā€¦ Source by Thomas Ciulla, MD, MBA Return to main website.